WaveLight AG / Strategic Company Decision 04.02.2008 Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad hoc communication according to § 15 WpHG (German Securities Trading Law) WaveLight AG: Alcon Laboratories, Inc. takes over the sales, service and support functions for WaveLights refractive product range in the USA Erlangen, February 04, 2008. With immediate effect, Alcon Laboratories, Inc. assumes all the commercial activities on the US medical technology market which have previously been the responsibility of the WaveLight, Inc., the US-subsidiary of the Erlangen based medical technology company WaveLight AG (company address: Am Wolfsmantel 5, 91058 Erlangen; ISIN: DE0005125603). As well as sales, service and support functions, marketing of the leading technology 'made in Germany' laser and diagnostic systems for ophthalmology will thus be assured by the closely meshed and effective distribution network of Alcon in the USA. Following the successful conclusion of the public take-over bid by Alcon, Inc., WaveLight AG is announcing today the restructuring of its organisation in the US-market. This agreement between WaveLight and Alcon includes a guaranteed volume of laser systems over a period of three years. As part of the agreement, WaveLight will continue to generate sales for the already installed equipment base of WaveLight laser systems in the USA from the 'Per Procedure Fee' usual there. In the framework of the 'Per Procedure Fee', the treating ophthalmologists paid a fixed amount to the manufacturer of the laser system for each defective vision correction on the eye. End of the ad hoc communication DGAP 04.02.2008 --------------------------------------------------------------------------- Language: English Issuer: WaveLight AG Am Wolfsmantel 5 91058 Erlangen Deutschland Phone: +49 (0)9131 - 61 86-0 Fax: +49 (0)9131 - 61 86-111 E-mail: info@wavelight.com Internet: www.wavelight.com ISIN: DE0005125603 WKN: 512560 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Hannover, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: WaveLight AG: Alcon Laboratories, Inc. takes over the sales, service and support functions for WaveLights refractive product range in the USA
| Source: EQS Group AG